J Med Microbiol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, T.
Right arrow Articles by Wang, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, T.
Right arrow Articles by Wang, J.
Agricola
Right arrow Articles by Wu, T.
Right arrow Articles by Wang, J.

The Journal of Medical Microbiology, Vol 44, Issue 4 311-316, Copyright © 1996 by Society for General Microbiology

JOURNAL ARTICLE

In-vitro proteinase production by oral Candida albicans isolates from individuals with and without HIV infection and its attenuation by antimycotic agents

T. Wu, L. P. Samaranayake, B. Y. Cao and J. Wang
Oral Biology Unit, Faculty of Dentistry, University of Hong Kong.

In-vitro proteinase production by oral Candida albicans isolates from patients with and without HIV infection (18 isolates from each group) was assessed by image analysis of a plate assay, with bovine serum albumin (BSA) as a substrate. The effect of sub-minimal inhibitory concentrations (sub-MICs) of nystatin, amphotericin B, clotrimazole and miconazole on in-vitro proteinase production by these yeast isolates was also investigated. Proteinase production by C. albicans isolates from patients with HIV infection was significantly greater than production by those from individuals without infection. All 18 isolates from HIV-infected individuals produced proteinase, in comparison to 56% of isolates from uninfected individuals. Pre-exposure of C. albicans isolates (seven proteinase producers from each group) to 1/4 and 1/16 MICs of nystatin, amphotericin B, clotrimazole and miconazole resulted in decreased proteinase production in all isolates tested. However, after exposure to the four antimycotic agents, proteinase production was decreased to a significantly greater extent in isolates from uninfected individuals than in those with HIV disease. Furthermore, when the relative concentration effect of antimycotic agents on proteinase production was compared, C. albicans isolates from the HIV-free group demonstrated a salient dose-response relationship compared with the HIV-infected group. These results indicate that C. albicans from patients with HIV infection are significantly more proteolytic than those from individuals without the infection, and that polyenes and imidazoles curtail the proteolytic activity of all C. albicans isolates, albeit to a lesser extent in those from HIV-infected patients. It appears that HIV disease favours oral colonisation by more proteolytic C. albicans isolates, with resilient proteolytic activity.


This article has been cited by other articles:


Home page
 J Med MicrobiolHome page
C. S. P. Tsang, F. C. S. Chu, W. K. Leung, L. J. Jin, L. P. Samaranayake, and S. C. Siu
Phospholipase, proteinase and haemolytic activities of Candida albicans isolated from oral cavities of patients with type 2 diabetes mellitus
J. Med. Microbiol., October 1, 2007; 56(10): 1393 - 1398.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
L. de Repentigny, D. Lewandowski, and P. Jolicoeur
Immunopathogenesis of Oropharyngeal Candidiasis in Human Immunodeficiency Virus Infection
Clin. Microbiol. Rev., October 1, 2004; 17(4): 729 - 759.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
A. Tavanti, G. Pardini, D. Campa, P. Davini, A. Lupetti, and S. Senesi
Differential Expression of Secretory Aspartyl Proteinase Genes (SAP1-10) in Oral Candida albicans Isolates with Distinct Karyotypes
J. Clin. Microbiol., October 1, 2004; 42(10): 4726 - 4734.
[Abstract] [Full Text] [PDF]

Home page
 Microbiol. Mol. Biol. Rev.Home page
J. R. Naglik, S. J. Challacombe, and B. Hube
Candida albicans Secreted Aspartyl Proteinases in Virulence and Pathogenesis
Microbiol. Mol. Biol. Rev., September 1, 2003; 67(3): 400 - 428.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
Y. Jin, H. K. Yip, Y. H. Samaranayake, J. Y. Yau, and L. P. Samaranayake
Biofilm-Forming Ability of Candida albicans Is Unlikely To Contribute to High Levels of Oral Yeast Carriage in Cases of Human Immunodeficiency Virus Infection
J. Clin. Microbiol., July 1, 2003; 41(7): 2961 - 2967.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
G. Luo, L. P. Samaranayake, and J. Y. Y. Yau
Candida Species Exhibit Differential In Vitro Hemolytic Activities
J. Clin. Microbiol., August 1, 2001; 39(8): 2971 - 2974.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
Y. H. Samaranayake and L. P. Samaranayake
Experimental Oral Candidiasis in Animal Models
Clin. Microbiol. Rev., April 1, 2001; 14(2): 398 - 429.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Newport and N. Agabian
KEX2 Influences Candida albicans Proteinase Secretion and Hyphal Formation
J. Biol. Chem., November 14, 1997; 272(46): 28954 - 28961.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 1996 Society for General Microbiology.